Participant characteristics and preference for prophylactic treatment.
| Questionnaire | Total (n = 151) | Yes to prophylaxis | No to prophylaxis | Odds ratio (95% CI) |
|---|---|---|---|---|
| Migraine frequency | ||||
| <2× per month | 50 (33.1) | 11 (22.0) | 39 (78.0) | |
| ≥2× per month | 101 (66.2) | 56 (55.4) | 45 (44.6) | 4.4 (2.0 to 9.6) |
| <5× per month | 111 (73.5) | 35 (31.5) | 76 (68.5) | |
| ≥5× per month | 40 (26.5) | 32 (80.0) | 8 (20.0) | 8.7 (3.6 to 20.8) |
| Migraine durationa | ||||
| <24 hours | 58 (38.9) | 23 (39.7) | 35 (60.3) | |
| ≥24 hours | 91 (61.1) | 43 (47.3) | 48 (52.7) | 1.4 (0.7 to 2.7) |
| <36 hours | 111 (74.5) | 45 (40.5) | 66 (59.5) | |
| ≥36 hours | 38 (25.5) | 21 (55.3) | 17 (44.7) | 1.8 (0.9 to 3.8) |
| Additional symptoms | ||||
| Not sensitive to light/sound | 32 (21.2) | 11 (34.4) | 21 (65.6) | |
| Sensitive to light/sound | 119 (78.8) | 56 (47.1) | 63 (52.9) | 1.7 (0.8 to 3.8) |
| Nausea/vomiting absent | 41 (27.2) | 16 (39.0) | 25 (61.0) | |
| Nausea/vomiting | 110 (72.8) | 51 (46.4) | 59 (53.6) | 1.4 (0.7 to 2.8) |
| Other | 49 (32.5) | 28 (57.1) | 21 (42.9) | |
| HIT-6 scoreb | ||||
| <60 | 31 (20.7) | 9 (29.0) | 22 (71.0) | |
| ≥60 | 119 (79.3) | 58 (48.7) | 61 (51.3) | 2.3 (1.0 to 5.5) |
| Electronic patient register | ||||
| Medication | ||||
| No triptan use | 72 (47.7) | 21 (29.2) | 51 (70.8) | |
| Triptan use | 79 (52.3) | 46 (58.2) | 33 (41.8) | 3.4 (1.7 to 6.7) |
| No medication | 41 (27.2) | 11 (26.8) | 30 (73.2) | |
| Analgesic use (excluding triptan use) | 31 (20.5) | 10 (32.3) | 21 (67.7) | 1.3 (0.5 to 3.6) |
| Consultation frequency | ||||
| Never | 86 (57.0) | 29 (33.7) | 57 (66.3) | |
| ≥1 in the previous year | 165 (43.0) | 38 (58.5) | 27 (41.5) | 2.8 (1.4 to 5.4) |